CRISPR enters its first human clinical trials
The gene editor targets cancer, blood disorders and blindness
![DNA scissors](https://i0.wp.com/www.sciencenews.org/wp-content/uploads/2019/08/080819_ti_crisprsicklecell_feat.jpg?fit=1028%2C579&ssl=1)
CUTTING ROOM Scientists will soon wield the molecular scissors CRISPR/Cas9 in the human body. Some people with a form of inherited blindness will have the gene editor injected into their eyes, where researchers hope it will snip out a mutation. Two other trials are CRISPR editing cells outside of the body to treat cancer or blood disorders.
traffic_analyzer/getty images plus